Table 1.
Median (range, %) | |
---|---|
Age, years | 56.3 (20.3–83.2) |
Gender | |
Male | 11 (35%) |
Female | 6 (65%) |
Tumor size, cm | 8.7 (5.3–21.7) |
Primary tumor location | |
Trunk | 4 (23.5%) |
Upper extremity | 3 (17.6%) |
Lower extremity | 10 (58.8%) |
Mitoses per 10 HPF | 7.5 (3–70) |
Neoadjuvant therapy | |
XRT only | 7 (41.2%) |
XRT + chemotherapy | 10 (58.8%) |
HPF: high-power fields
XRT: radiation therapy